Solugen is a venture-backed biotech startup that produces high-performance chemicals from plant-derived substitutes. Our award-winning hydrogen peroxide technology was developed in-house by a team of doctors, scientists, and engineers from MIT. Solugen is a manufacturer and supplier of registered biocides and specialty bio-based solutions for divalent control in process flow assurance and asset integrity. Solugen's patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with the competition.
Founded in 2016 by Gaurab Chakrabarti, M.D., Ph.D., and Sean Hunt, Ph.D., Solugen are a venture-backed specialty chemicals company that applies industrial biotechnology and green chemistry principles to re-design the production of a variety of end-use and novel chemicals. The company’s first product, BioPeroxide™, was created using patented enzymatic technology to convert plant sugars into hydrogen peroxide and was followed by the manufacturing of a comprehensive line of products such as their flagship ScaleSol™ and BioChelate™ solutions.
Total Funding: $55.2 M
Funding Stage: Series B
Business Stage: Scaling Up
Market: B2B
Company Size: 101 to 250
Founded: 2016
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at Solugen
SH&E Manager – Operations and R&D
Houston, Texas
Process Technician Lead
Houston, Texas
Process Development R&D Engineer 1
Houston, Texas
Process Development Engineering Intern (Summer 2021)
Houston, Texas
Marketing Director
Houston, Texas